NCT03908905

Brief Summary

Chronic widespread pain (CWP), defined as long-lasting pain in multiple body regions, has a prevalence of 10-14% in Europe and is associated with other physical symptoms such as fatigue and cognitive problems. Individuals with longstanding pain also have a high prevalence of sleep disturbances, and sleep problems can in itself lead to tiredness, lower neurocognitive function and higher pain ratings. However, studies of comorbid sleep problems for individuals with CWP are a lacking, and the primary aim for the present study is to assess the prevalence of sleep disturbances in individuals with CWP, and to see how this covariates with pain, fatigue, activity level, neurocognitive functioning, and biomarkers. As a secondary aim the study will assess a subgroup of the individuals, that has received multimodal pain management treatment, a second time after 6 months to analyze how the prevalence of sleep disturbances and other associated problems covaries over time.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
96

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 8, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 9, 2019

Completed
5 months until next milestone

Study Start

First participant enrolled

September 1, 2019

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

February 29, 2024

Status Verified

February 1, 2024

Enrollment Period

5.3 years

First QC Date

April 8, 2019

Last Update Submit

February 27, 2024

Conditions

Keywords

PainSleepNeuropsychologyFatigueActivity levelAttentionExecutive functionMemory

Outcome Measures

Primary Outcomes (1)

  • Polysomnography

    Assessment of objective sleep problems

    6 months

Secondary Outcomes (5)

  • CANTAB

    6 months

  • Actigraph

    6 months

  • Biomarkers

    6 months

  • Pain level

    6 months

  • Fatigue

    6 months

Study Arms (1)

Intervention

Diagnostic Test: Polysomnography

Interventions

PolysomnographyDIAGNOSTIC_TEST

Sleep screening, neurocognitive assessment, activity monitoring questionnaires, blood sample

Intervention

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All subjects that are referred for an inpatient multidisciplinary analysis of complex chronic pain conditions at a regional pain center at Uppsala University Hospital.

You may qualify if:

  • Chronic Widespread Pain

You may not qualify if:

  • Other untreated and or serious psychiatric or somatic conditions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uppsala university hospital

Uppsala, Uppsala County, 752 60, Sweden

Location

Biospecimen

Retention: SAMPLES WITHOUT DNA

Plasma

MeSH Terms

Conditions

Chronic PainParasomniasPainFatigue

Interventions

Polysomnography

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSleep Wake DisordersNervous System DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Monitoring, PhysiologicDiagnostic Techniques and ProceduresDiagnosis

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2019

First Posted

April 9, 2019

Study Start

September 1, 2019

Primary Completion

December 30, 2024

Study Completion

June 30, 2025

Last Updated

February 29, 2024

Record last verified: 2024-02

Locations